Extracellular matrix metalloproteinase inducer is a negative prognostic factor of pediatric medulloblastoma

Pathology and Oncology Research

Volumn 17, Issue 3, 2011, Pages 705-711

  Chu, Tongwei ^a   Chen, Xiaoyang ^b   Yu, Jie ^c   Xiao, Jianwen ^c   Fu, Zhou ^c  

^a Xinqiao Hospital   (China)

^b SHANTOU UNIVERSITY   (China)

^c CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Extracellular matrix metalloproteinase inducer; Immunohistochemistry; Medulloblastoma; Prognosis

Indexed keywords

CD147 ANTIGEN; ONCOPROTEIN;

ARTICLE; CANCER STAGING; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; OVERALL SURVIVAL; PRESCHOOL CHILD; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCHOOL CHILD; UPREGULATION;

ANTIGENS, CD147; CARCINOMA; CARCINOMA, LARGE CELL; CEREBELLAR NEOPLASMS; CEREBELLUM; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MEDULLOBLASTOMA; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 80052717930     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-011-9373-z     Document Type: Article

References (25)

1. MD Ris R Packer J Goldwein, et al. 2001 Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a children's cancer group study J Clin Oncol 19 3470 6 11481352 1:STN:280:DC%2BD3MvjtlOmsw%3D%3D (Pubitemid 32730083)
2. RE Taylor CC Bailey K Robinson, et al. 2003 Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study J Clin Oncol 21 1581 91 12697884 10.1200/JCO.2003.05.116 1:CAS:528:DC%2BD2cXptlCksLk%3D (Pubitemid 46594113)
3. SL Wolden IJ Dunkel MM Souweidane, et al. 2003 Patterns of failure using a conformal radiation therapy tumor bed boost for medulloblastoma J Clin Oncol 21 3079 83 12915597 10.1200/JCO.2003.11.140 (Pubitemid 46606288)
4. JG Douglas JL Barker RG Ellenbogen, et al. 2004 Concurrent chemotherapy and reduced-dose cranial spinal irradiation followed by conformal posterior fossa tumor bed boost for average-risk medulloblastoma: efficacy and patterns of failure Int J Radiat Oncol Biol Phys 58 1161 4 15001259 10.1016/j.ijrobp.2003. 09.010 (Pubitemid 38314800)
5. EE Gabison S Mourah E Steinfels 2005 Differential expression of extracellular matrix metalloproteinase inducer (CD147) in normal and ulcerated corneas Am J Pathol 166 209 19 15632013 10.1016/S0002-9440(10)62245-6 1:CAS:528:DC%2BD2MXnt1eqsQ%3D%3D
6. KP TangY MT Nakada L Yan 2004 Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN Mol Cancer Res 2 73 80 (Pubitemid 38250423)
7. Y Tang MT Nakada P Kesavan, et al. 2005 Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases Cancer Res 65 3193 9 15833850 1:CAS:528:DC%2BD2MXjt1yktb4%3D (Pubitemid 40524601)
8. EA Marieb A Zoltan-Jones R Li, et al. 2004 Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan production Cancer Res 64 1229 32 14983875 10.1158/0008-5472.CAN-03- 2832 1:CAS:528:DC%2BD2cXhtleisLk%3D (Pubitemid 38235586)
9. JM Yang P O'Neill W Jin, et al. 2006 Extracellular matrix metalloproteinase inducer (CD147) confers resistance of breast cancer cells to anoikis through inhibition of Bim J Biol Chem 281 9719 27 16443928 10.1074/jbc.M508421200 1:CAS:528:DC%2BD28XjtVSqsbk%3D (Pubitemid 43864690)
10. N Vignesw S Beckers S Waigel, et al. 2006 Increased EMMPRIN (CD 147) expression during oral carcinogenesis Exp Mol Pathol 80 147 59 10.1016/j.yexmp.2005.09.011
11. JY Dai KF Dou CH Wang, et al. 2009 The interaction of HAb18G/CD147 with integrin α6β1 and its implications for the invasion potential of human hepatoma cells BMC Cancer 9 337 19775453 10.1186/1471-2407-9-337
12. Y Ishibashi T Matsumoto M Niwa, et al. 2004 CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma Cancer 101 1994 2000 15372476 10.1002/cncr.20593 1:CAS:528:DC%2BD2cXhtVShtb7M (Pubitemid 39425374)
13. TR Gershon OJ Becher 2006 Medulloblastoma: therapy and biologic considerations Curr Neurol Neurosci Rep 6 200 206 16635428 10.1007/s11910-006- 0006-y
14. RI Jakacki 2005 Treatment strategies for high-risk medulloblastoma and supratentorial primitive neuroectodermal tumors. Review of the literature J Neurosurg 102 Suppl 1 44 52 16206733 (Pubitemid 44955009)
15. JM Yang Z Xu H Wu 2003 Overexpression of extracellular matrixmetalloproteinase inducer in multidrug resistant cancer cells Mol Cancer Res 1 420 7 12692261 1:CAS:528:DC%2BD3sXivFygt70%3D (Pubitemid 36459252)
16. C Thorns MH FellerAC 2002 EMMPRIN (CD147) is expressed in Hodgkin's lymphoma and anaplastic large cell lymphoma. An immunohistochemical study of 60 cases Anticancer Res 22 1983 6 12174874 1:CAS:528:DC%2BD38XmsF2lsLc%3D (Pubitemid 34857013)
17. BL Maria N Gupta AG Gilg, et al. 2008 Targeting hyaluronan interactions in spinal cord astrocytomas and diffuse pontine gliomas J Child Neurol 23 1214 20 18952588 10.1177/0883073808321771
18. ChaoYC TsaiWC WH Lee, et al. 2006 Inc reasing EMMPRIN and matriptase expression in hepatocellular carcinoma: tissue microarray analysis of immunohistochemical scores with clinicopathological parameters Histopathology 49 388 95 10.1111/j.1365-2559.2006.02516.x 1:STN:280:DC%2BD28rlsVSktg%3D%3D (Pubitemid 44401546)
19. N Reimers AssmannV ZafrakasK, et al. 2004 Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells Clin Cancer Res 10 3422 8 15161697 10.1158/1078-0432.CCR-03-0610 1:CAS:528:DC%2BD2cXkt1GhsLc%3D (Pubitemid 38685448)
20. B Davidson S Konstantinovsky S Nielsen, et al. 2004 ltered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression Clin Cancer Res 10 7335 46 15534110 10.1158/1078-0432.CCR-04-0183 1:CAS:528:DC%2BD2cXpsVKlu74%3D (Pubitemid 39487723)
21. B Davidson I Goldberg A Berner, et al. 2003 EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma Clin Exp Metastasis 20 161 9 12705637 10.1023/A:1022696012668 1:CAS:528:DC%2BD3sXhslOkt74%3D (Pubitemid 36403281)
22. S Menashi M Serova L Ma, et al. 2003 (2003) Regulation of extracellular matrix metalloproteinase inducer matrix metalloproteinase expression by amphiregulin in transformed human breast epithelial cells Cancer Res 63 7575 80 14633669 1:CAS:528:DC%2BD3sXptFOlsrc%3D (Pubitemid 37466675)
23. L Jia W Wei J Cao H Xu X Miao J Zhang 2009 Silencing CD147 inhibits tumor progression and increases chemosensitivity in murine lymphoid neoplasm P388D1 cells Ann Hematol 88 753 60 19125248 10.1007/s00277-008-0678-2 1:CAS:528:DC%2BD1MXntlSgsbs%3D
24. YH Kuang X Chen J Su, et al. 2009 RNA interference targeting the CD147 induces apoptosis of multi-drug resistant cancer cells related to XIAP depletion Cancer Lett 276 189 95 19097686 10.1016/j.canlet.2008.11.010 1:CAS:528:DC%2BD1MXisFKjsLc%3D
25. RJ Packer BR Rood TJ MacDonald 2003 Medulloblastoma: present concepts of stratification into risk groups Pediatr Neurosurg 39 60 7 12845195 10.1159/000071316 (Pubitemid 36829097)